{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:17:30Z","timestamp":1792145850174,"version":"4.4.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2018YFE0192600"],"award-info":[{"award-number":["2018YFE0192600"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31672610"],"award-info":[{"award-number":["31672610"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Niclosamide is commonly used as an antiparasitic drug in veterinary clinics. The objectives of this study were to evaluate the efficacy of niclosamide against resistant Gram-positive bacteria in vitro and in an in vivo experimental model of topical bacterial infection. Moreover, to study the antibacterial mechanism of niclosamide to Staphylococcus aureus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A mouse topical infection model was established to detect the antibacterial activity of niclosamide in vivo. The antimicrobial mechanism was probed by visualizing the bacterial morphologies using scanning electron microscopy and transmission electron microscopy. Moreover, the haemolytic assay and western blotting analysis were performed to evaluate whether niclosamide could inhibit the secretion of alpha-haemolysin (\u03b1-HL) from S. aureus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The MICs of niclosamide were below 0.5\u2005mg\/L for Gram-positive bacteria, showing excellent antibacterial activity in vitro. The in vivo antibacterial activity results indicated that niclosamide treatment at 10\u2005mg\/kg of body weight caused a significant reduction in the abscess area and the number of S. aureus cells. Moreover, the antibacterial mechanism of niclosamide showed that the surface morphology of S. aureus displayed noticeable shrinkage, with an increasing number of small vacuole-like structures observed as the drug concentration increased. Intracellular ATP levels were found to decrease in a niclosamide dose-dependent manner. Haemolysis and western blotting analyses revealed that niclosamide inhibited the haemolytic activity of S. aureus by inhibiting \u03b1-HL expression under subinhibitory concentration conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Niclosamide has significant potential for development into drugs that prevent and treat diseases caused by Gram-positive bacteria such as Staphylococcus and Streptococcus.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkac319","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T10:41:44Z","timestamp":1662028904000},"page":"3312-3320","source":"Crossref","is-referenced-by-count":29,"title":["Niclosamide as a repurposing drug against Gram-positive bacterial infections"],"prefix":"10.1093","volume":"77","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , Shanghai 200241 , China"},{"name":"Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs , Shanghai 200241 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Ran","sequence":"additional","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , Shanghai 200241 , China"},{"name":"Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs , Shanghai 200241 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Shang","sequence":"additional","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , Shanghai 200241 , China"},{"name":"Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs , Shanghai 200241 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , Shanghai 200241 , China"},{"name":"Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs , Shanghai 200241 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , Shanghai 200241 , China"},{"name":"Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs , Shanghai 200241 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenzhong","family":"Fei","sequence":"additional","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , Shanghai 200241 , China"},{"name":"Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs , Shanghai 200241 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Chen","sequence":"additional","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , Shanghai 200241 , China"},{"name":"Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs , Shanghai 200241 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gu","sequence":"additional","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , Shanghai 200241 , China"},{"name":"Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs , Shanghai 200241 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Liu","sequence":"additional","affiliation":[{"name":"Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences , Shanghai 200241 , China"},{"name":"Key Laboratory of Veterinary Chemical Drugs and Pharmaceutics, Ministry of Agriculture and Rural Affairs , Shanghai 200241 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"2022112816495921400_dkac319-B1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.coph.2014.09.006","article-title":"Update on the antibiotic resistance crisis","volume":"18","author":"Rossolini","year":"2014","journal-title":"Curr Opin Pharmacol"},{"key":"2022112816495921400_dkac319-B2","doi-asserted-by":"crossref","first-page":"123980","DOI":"10.1016\/j.cej.2019.123980","article-title":"Multifunctional therapeutic strategy of Ag-synergized dual-modality upconversion nanoparticles to achieve the rapid and sustained cidality of methicillin-resistant Staphylococcus aureus","volume":"385","author":"Zhao","year":"2020","journal-title":"Chem Eng J"},{"key":"2022112816495921400_dkac319-B3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","article-title":"Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research","volume":"17","author":"Turner","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"2022112816495921400_dkac319-B4","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/jac\/dkac119","article-title":"Persistence of a multidrug-resistant worldwide-disseminated methicillin-resistant Staphylococcus epidermidis clone harbouring the cfr linezolid resistance gene in a French hospital with evidence of interspecies transfer to several Staphylococcus aureus lineages","volume":"77","author":"C\u00f4rtes","year":"2022;","journal-title":"J Antimicrob Chemother"},{"key":"2022112816495921400_dkac319-B5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/jac\/dkr110","article-title":"Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model","volume":"66","author":"Zhanel","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2022112816495921400_dkac319-B6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/jac\/dkp176","article-title":"Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model","volume":"64","author":"Zhanel","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"2022112816495921400_dkac319-B7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nchembio.559","article-title":"Combinations of antibiotics and non-antibiotic drugs enhance antimicrobial efficacy","volume":"7","author":"Ejim","year":"2011","journal-title":"Nature Chem Biol"},{"key":"2022112816495921400_dkac319-B8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41429-019-0186-8","article-title":"Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli","volume":"72","author":"Domalaon","year":"2019","journal-title":"J Antibiot"},{"key":"2022112816495921400_dkac319-B9","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1093\/jac\/dkq353","article-title":"Repurposing FDA-approved drugs to combat drug-resistant Acinetobacter baumannii","volume":"65","author":"Chopra","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2022112816495921400_dkac319-B10","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/jac\/dkr154","article-title":"Identi\ufb01cation of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae","volume":"66","author":"Chopra","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2022112816495921400_dkac319-B11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"2022112816495921400_dkac319-B12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2022112816495921400_dkac319-B13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0163-7258(82)90064-X","article-title":"The biology and toxicology of molluscicides, bayluscide","volume":"19","author":"Andrews","year":"1982","journal-title":"Pharmacol Ther"},{"key":"2022112816495921400_dkac319-B14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0099-5428(05)32002-8","article-title":"Niclosamide: comprehensive profile","volume":"32","author":"Al-Hadiya","year":"2005","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"key":"2022112816495921400_dkac319-B15","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.21873\/anticanres.14082","article-title":"Antihelminthic niclosamide induces autophagy and delayed apoptosis in human non-small lung cancer cells in vitro and in vivo","volume":"40","author":"Chai","year":"2020","journal-title":"Anticancer Res"},{"key":"2022112816495921400_dkac319-B16","doi-asserted-by":"crossref","first-page":"113610","DOI":"10.1016\/j.bcp.2019.08.012","article-title":"Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathway","volume":"169","author":"Zhu","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"2022112816495921400_dkac319-B17","doi-asserted-by":"crossref","first-page":"198277","DOI":"10.1016\/j.virusres.2020.198277","article-title":"Repurposing of antiparasitic niclosamide to inhibit respiratory syncytial virus (RSV) replication","volume":"295","author":"Niyomdecha","year":"2021","journal-title":"Virus Res"},{"key":"2022112816495921400_dkac319-B18","doi-asserted-by":"crossref","first-page":"e04050","DOI":"10.1016\/j.heliyon.2020.e04050","article-title":"Inhibition of human immunodeficiency virus type 1 by niclosamide through mTORC1 inhibition","volume":"6","author":"Niyomdecha","year":"2020","journal-title":"Heliyon"},{"key":"2022112816495921400_dkac319-B19","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1128\/AAC.48.7.2693-2696.2004","article-title":"Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide","volume":"48","author":"Wu","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2022112816495921400_dkac319-B20","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbrc.2020.09.071","article-title":"Niclosamide activates the AMP-activated protein kinase complex containing the \u03b22 subunit independently of AMP","volume":"533","author":"Suzuki","year":"2020","journal-title":"Biochem Bioph Res Co"},{"key":"2022112816495921400_dkac319-B21","doi-asserted-by":"crossref","first-page":"155250","DOI":"10.1016\/j.cyto.2020.155250","article-title":"The role of WNT\/\u03b2-catenin signaling pathway and glutamine metabolism in the pathogenesis of CCl4-induced liver fibrosis: repositioning of niclosamide and concerns about lithium","volume":"136","author":"El-Ashmawy","year":"2020","journal-title":"Cytokine"},{"key":"2022112816495921400_dkac319-B22","doi-asserted-by":"crossref","first-page":"173438","DOI":"10.1016\/j.ejphar.2020.173438","article-title":"Niclosamide attenuates lung vascular remodeling in experimental pulmonary arterial hypertension","volume":"887","author":"Braga","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"2022112816495921400_dkac319-B23","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.jid.2016.06.624","article-title":"Improvement of sclerodermatous graft-versus-host disease in mice by niclosamide","volume":"136","author":"Morin","year":"2016","journal-title":"J Invest Dermatol"},{"key":"2022112816495921400_dkac319-B24","first-page":"0124595","article-title":"Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus","volume":"4","author":"Rajamuthiah","year":"2015","journal-title":"PLoS One"},{"key":"2022112816495921400_dkac319-B25","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ijantimicag.2018.02.003","article-title":"Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci","volume":"51","author":"Mohammad","year":"2018","journal-title":"Int J Antimicrob Ag"},{"key":"2022112816495921400_dkac319-B26","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1038\/s41598-018-22037-x","article-title":"Repurposing the anthelmintic drug niclosamide to combat Helicobacter","volume":"8","author":"Tharmalingam","year":"2018","journal-title":"Sci Rep"},{"key":"2022112816495921400_dkac319-B27","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.bmcl.2019.03.032","article-title":"Discovery of niclosamide and its O-alkylamino-tethered derivatives as potent antibacterial agents against carbapenemase-producing and\/or colistin resistant Enterobacteriaceae isolates","volume":"29","author":"Xu","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"2022112816495921400_dkac319-B28","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1038\/s41467-018-07705-w","article-title":"Host-targeted niclosamide inhibits C. dif\ufb01cile virulence and prevents disease in mice without disrupting the gut microbiota","volume":"9","author":"Tam","year":"2018","journal-title":"Nat Commun"},{"key":"2022112816495921400_dkac319-B29","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/jac\/dkac044","article-title":"Adaptation of clinical isolates of Klebsiella pneumoniae to the combination of niclosamide with the efflux pump inhibitor phenyl-arginine-\u03b2-naphthylamide (Pa\u03b2N): co-resistance to antimicrobials","volume":"77","author":"Pacios","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2022112816495921400_dkac319-B30","doi-asserted-by":"crossref","first-page":"e02574-18","DOI":"10.1128\/AAC.02574-18","article-title":"The anthelmintic drug niclosamide synergizes with colistin and reverses colistin resistance in Gram-negative bacilli","volume":"63","author":"Domalaon","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2022112816495921400_dkac319-B31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fcimb.2018.00348","article-title":"Synergistic activity of niclosamide in combination with colistin against colistin-susceptible and colistin-resistant Acinetobacter baumannii and Klebsiella pneumoniae","volume":"8","author":"Ayerbe-Algaba","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"2022112816495921400_dkac319-B32","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing\u2014Twenty-Seventh Edition: M100","author":"CLSI","year":"2017"},{"key":"2022112816495921400_dkac319-B33","doi-asserted-by":"crossref","first-page":"103632","DOI":"10.1016\/j.fm.2020.103632","article-title":"Action mode of cranberry anthocyanin on physiological and morphological properties of Staphylococcus aureus and its application in cooked meat","volume":"94","author":"Gong","year":"2021","journal-title":"Food Microbiol"},{"key":"2022112816495921400_dkac319-B34","doi-asserted-by":"crossref","first-page":"112903","DOI":"10.1016\/j.jim.2020.112903","article-title":"Development of a mechanism of action reflective and robust potency assay for a therapeutic antibody against alpha toxin using rabbit erythrocytes","volume":"488","author":"Wang","year":"2021","journal-title":"J Immunol Methods"},{"key":"2022112816495921400_dkac319-B35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.fitote.2013.02.001","article-title":"Inhibition of alpha-toxin production by subinhibitory concentrations of naringenin controls Staphylococcus aureus pneumonia","volume":"86","author":"Zhang","year":"2013","journal-title":"Fitoterapia"},{"key":"2022112816495921400_dkac319-B36","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/antibiotics11050651","article-title":"Niclosamide as a repurposing drug against Corynebacterium striatum multidrug-resistant infections","volume":"11","author":"Folliero","year":"2022","journal-title":"Antibiotics"},{"key":"2022112816495921400_dkac319-B37","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/2211016a0","article-title":"Mechanism of action of reagents that uncouple oxidative phosphorylation","volume":"221","author":"Weinbach","year":"1969","journal-title":"Nature"},{"key":"2022112816495921400_dkac319-B38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10482-015-0491-6","article-title":"Diosmetin inhibits the expression of alpha-hemolysin in Staphylococcus aureus","volume":"108","author":"Liu","year":"2015","journal-title":"Anton Leeuw"},{"key":"2022112816495921400_dkac319-B39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bej.2003.08.010","article-title":"ATP requirements for growth and maintenance of iron-oxidizing bacteria","volume":"18","author":"Mignone","year":"2004","journal-title":"Biochem Eng J"},{"key":"2022112816495921400_dkac319-B40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/CMR.13.1.16","article-title":"Exotoxins of Staphylococcus aureus","volume":"13","author":"Dinges","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"2022112816495921400_dkac319-B41","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/508210","article-title":"Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis","volume":"194","author":"Xiong","year":"2006","journal-title":"J Infect Dis"},{"key":"2022112816495921400_dkac319-B42","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/IAI.01313-06","article-title":"Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia","volume":"75","author":"Wardenburg","year":"2007","journal-title":"Infect Immun"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/12\/3312\/47369572\/dkac319.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/12\/3312\/47369572\/dkac319.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T11:55:40Z","timestamp":1669636540000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/77\/12\/3312\/6730838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,9,29]]},"published-print":{"date-parts":[[2022,11,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkac319","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,1]]},"published":{"date-parts":[[2022,9,29]]}}}